Abbott Laboratories vs ResMed — CEO Pay Comparison
Robert Ford (Abbott Laboratories) earns $4.0M more in total compensation than Mick Farrell (ResMed).
| Metric | Abbott LaboratoriesABT | ResMedRMD |
|---|---|---|
| CEO | Robert Ford | Mick Farrell |
| Industry | Medical Devices | Medical Devices |
| Total Compensation | $12.0M | $8.0M |
| Base Salary | $1.2M | $800K |
| Stock Awards | $6.0M | $4.0M |
| Option Awards | $1.4M | $960K |
| Non-Equity Incentive | $1.8M | $1.2M |
| Pay-for-Performance Grade | C (63/100) | B (78/100) |
| CEO-Worker Pay Ratio | 133:1 | 89:1 |
| Median Worker Pay | $90K | $90K |
| Say-on-Pay Approval | 85.6% | 96.3% |
| 3yr Total Shareholder Return | +3.2% | +12.7% |
| Revenue | $40.1B | $4.7B |
| Market Cap | $210.0B | $32.0B |
| Employees | 114,000 | 10,000 |
Analysis
Robert Ford (Abbott Laboratories) earns $12.0M in total compensation, while Mick Farrell (ResMed) earns $8.0M. That is a difference of $4.0M.
On pay-for-performance alignment, Abbott Laboratories scores C (63/100) while ResMed scores B (78/100). ResMed's CEO compensation is better aligned with company performance.
Abbott Laboratories's CEO-to-worker pay ratio is 133:1 compared to ResMed's 89:1. Shareholders approved CEO pay at 85.6% (Abbott Laboratories) and 96.3% (ResMed).